Alveolar-like Macrophages Attenuate Respiratory Syncytial Virus Infection

Respiratory Syncytial Virus (RSV) is the leading cause of acute lower respiratory infections in young children and infection has been linked to the development of persistent lung disease in the form of wheezing and asthma. Despite substantial research efforts, there are no RSV vaccines currently ava...

Full description

Bibliographic Details
Published in:	Viruses
Main Authors:	Bárbara N. Porto, Michael L. Litvack, Yuchen Cen, Irene Lok, Sheena Bouch, Michael J. Norris, Wenming Duan, Cameron Ackerley, Martin Post, Theo J. Moraes
Format:	Article
Language:	English
Published:	MDPI AG 2021-09-01
Subjects:	Respiratory Syncytial Virus alveolar macrophages stem cells respiratory infection
Online Access:	https://www.mdpi.com/1999-4915/13/10/1960

Similar Items

Possible respiratory syncytial virus infection presenting as diffuse alveolar hemorrhage in an elderly treated with systemic corticosteroid: A case report
by: Kyung Hun Nam, MD MPH, et al.
Published: (2021-01-01)

Resurgence of Respiratory Syncytial Virus in Children: An Out-of-Season Epidemic in Portugal
by: Ana Rita Torres, et al.
Published: (2023-01-01)

Prevention and Treatment Strategies for Respiratory Syncytial Virus (RSV)
by: Dvir Gatt, et al.
Published: (2023-01-01)

Respiratory syncytial virus groups A and B in Porto Alegre, Brazil, from 1990 to 1995 and 1998
by: Straliotto Selir M, et al.
Published: (2001-01-01)

The Impact of Palivizumab for Respiratory Syncytial Virus Prophylaxis on Preschool Childhood Asthma
by: Hannah Ora Hasson, et al.
Published: (2024-11-01)

Respiratory Syncytial Virus Reinfections in Children in Western Australia
by: David A. Foley, et al.
Published: (2023-12-01)

Cost-effectiveness of bivalent respiratory syncytial virus prefusion F vaccine for prevention of respiratory syncytial virus among older adults in Germany
by: Ahuva Averin, et al.
Published: (2025-12-01)

Respiratory syncytial virus under 2 years of age: hospitalization trends and risk factors for severe disease â preliminary data from the Portuguese sentinel network
by: Ana R. Torres, et al.
Published: (2024-01-01)

Improving the quality of care of respiratory syncytial virus in the neonatal and pediatric populations globally
by: Fungwe Jah, et al.
Published: (2025-05-01)

Liposomal Glutathione Augments Immune Defenses against Respiratory Syncytial Virus in Neonatal Mice Exposed in Utero to Ethanol
by: Theresa W. Gauthier, et al.
Published: (2024-01-01)

Respiratory Syncytial Virus Vaccines for the Prevention of Lower Respiratory Tract Infections in Patients Living with Chronic Obstructive Pulmonary Disease: A Rapid Review
by: Paul M. Boylan, et al.
Published: (2024-01-01)

Hospitalization in pregnancy due to human respiratory syncytial virus associated disease
by: Janelle Santos, et al.
Published: (2023-01-01)

Human Respiratory Syncytial Virus NS2 Protein Induces Autophagy by Modulating Beclin1 Protein Stabilization and ISGylation
by: Kim Chiok, et al.
Published: (2022-02-01)

ACUTE RESPIRATORY SYNCYTIAL VIRUS INFECTION IN CHILDREN IN THE AGE ASPECT
by: V. B. Rovny, et al.
Published: (2015-08-01)

Respiratory syncytial virus infection as a cause of hospitalization in population under 1 year in Colombia
by: Juan Gabriel Piñeros, et al.
Published: (2013-11-01)

Palivizumab for the Prophylaxis of Respiratory Syncytial Virus Disease: Expert Opinion and Recommendations for the Gulf Cooperation Council Region
by: Adel S. Alharbi, et al.
Published: (2024-09-01)

Effectiveness of palivizumab immunoprophylaxis in infants with respiratory syncytial virus disease in Colombia
by: Juan Gabriel Piñeros, et al.
Published: (2021-11-01)

Respiratory Syncytial Virus in Pregnant Women: Systematic Review and Meta-Analysis
by: Matteo Riccò, et al.
Published: (2022-06-01)

Protection and mechanism of action of a novel human respiratory syncytial virus vaccine candidate based on the extracellular domain of small hydrophobic protein
by: Bert Schepens, et al.
Published: (2014-10-01)

Anti-RSV Peptide-Loaded Liposomes for the Inhibition of Respiratory Syncytial Virus
by: Sameer Joshi, et al.
Published: (2018-05-01)

Generation of nanobodies against the F protein of respiratory syncytial virus and establishment of an indirect immunofluorescence assay
by: Qianqian Wang, et al.
Published: (2025-07-01)

Respiratory syncytial virus infection and the need for immunization in Korea
by: Hye Young Kim, et al.
Published: (2023-12-01)

Standardized Phylogenetic Classification of Human Respiratory Syncytial Virus below the Subgroup Level
by: Stephanie Goya, et al.
Published: (2024-08-01)

Circulation of Respiratory Syncytial Virus (RSV) in Poland Between Seasons of 2009/2010 and 2022/2023 Based on SENTINEL System
by: Karol Szymański, et al.
Published: (2025-01-01)

Respiratory syncytial virus in pediatric patients admitted to a tertiary center in Amman: clinical characteristics, and age-related patterns
by: Montaha Al-Iede, et al.
Published: (2024-05-01)

Adherence to Palivizumab for Respiratory Syncytial Virus Prophylaxis in Romanian Infants
by: Andreea Calomfirescu-Avramescu, et al.
Published: (2025-02-01)

Immune Responses to Respiratory Syncytial Virus Vaccines: Advances and Challenges
by: Gabriela Souza da Silva, et al.
Published: (2024-11-01)

A practical guidance on the prevention and treatment of childhood respiratory syncytial virus infection in Kurdistan
by: Azad A. Haleem, et al.
Published: (2025-03-01)

Epidemiology and genetic diversity of human respiratory syncytial virus in Belgium between 2011 and 2019
by: Kaat Ramaekers, et al.
Published: (2024-10-01)

Frequency of Respiratory Syncytial Virus Among Hospitalized Children with Acute Lower Respiratory Tract Infections
by: Murtaza Hussain, et al.
Published: (2022-12-01)

CLINICAL AND PATHOMORPHOLOGICAL MANIFESTATIONS OF RESPIRATORY SYNCYTIAL VIRUS INFECTION. CASE REPORT
by: I. V. Babachenko, et al.
Published: (2018-04-01)

Necrotizing Enterocolitis Due to Respiratory Syncytial Virus in a Newborn Baby
by: Mahli Batuhan Özdoğar, et al.
Published: (2025-08-01)

New Developments and Challenges in Antibody-Based Therapies for the Respiratory Syncytial Virus
by: Diethelm-Varela B, et al.
Published: (2023-04-01)

The effectiveness of nirsevimab in reducing the burden of disease due to respiratory syncytial virus (RSV) infection over time in the Madrid region (Spain): a prospective population-based cohort study
by: José Francisco Barbas Del Buey, et al.
Published: (2024-08-01)

Protein and Peptide Substances in the Treatment of Respiratory Syncytial Infection: Current State
by: Anna A. Shtro, et al.
Published: (2022-03-01)

Genomic Sequencing Surveillance to Identify Respiratory Syncytial Virus Mutations, Arizona, USA
by: LaRinda A. Holland, et al.
Published: (2023-11-01)

Detailed Evolutionary Analyses of the F Gene in the Respiratory Syncytial Virus Subgroup A
by: Mariko Saito, et al.
Published: (2021-12-01)

Characteristics of respiratory syncytial virus infection in children in Pudong New Area， Shanghai， 2013‒2023
by: YU Qiumiao, et al.
Published: (2025-05-01)

Cohort profile: A population-based record linkage platform to address critical epidemiological evidence gaps in respiratory syncytial virus and other respiratory infections
by: Mohinder (Minda) Sarna, et al.
Published: (2024-04-01)

Burden of Respiratory Syncytial Virus Related Acute Lower Respiratory Tract Infection in Hospitalized Thai Children: A 6-Year National Data Analysis
by: Phanthila Sitthikarnkha, et al.
Published: (2022-12-01)